Effect of Endoplasmic Reticulum Stress on Metabolic Function.
Phase of Trial: Phase II
Latest Information Update: 05 May 2015
At a glance
- Drugs Sodium phenylbutyrate (Primary) ; Tauroursodeoxycholic acid (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 29 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 09 Dec 2013 Planned end Ddte changed from 1 Sep 2011 to 1 Dec 2014 as reported by ClinicalTrials.gov.